Davine Hofste Op Bruinink
5PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 18, 2025
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.Cathelijne Fokkema, Luca Bertamini, Madelon M E de Jong
|Jun 01, 2022
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.Kristine Misund, Davine Hofste Op Bruinink, Eivind Coward
|Mar 31, 2022
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin
|Jun 04, 2021
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial.Stefania Oliva, Davine Hofste Op Bruinink, Lucie Rihova
|May 21, 2021
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape.Madelon M E de Jong, Zoltán Kellermayer, Natalie Papazian
Pageof 1
Frequent Collaborators
3 joint publications
Pieter Sonneveld
3 joint publications
Vincent H J van der Velden
2 joint publications
Tom Cupedo
1 joint publications
Zoltán Kellermayer
1 joint publications
Stefania Oliva
1 joint publications
Mario Boccadoro
1 joint publications
Rowan Kuiper
1 joint publications
Mark van Duin
1 joint publications
Remco Hoogenboezem
1 joint publications
Bronno van der Holt
